價格 | 詢價 | ||
包裝 | 1支 | 1支 | 1支 |
最小起訂量 | 1支 |
發(fā)貨地 | 湖北 |
更新日期 | 2025-01-16 |
英文名稱:Research Grade Vulinacimab (DHE16605) | CAS:2250342-36-8 |
純度規(guī)格: PAGE:>95% | 產(chǎn)品類別: 藥物對照抗體 |
抗體名: Research Grade Vulinacimab (DHE16605) | 靶點: VEGFR-2, KDR |
宿主: Homo sapiens | 適應(yīng)物種: Human |
克隆性: Monoclonal | 藥物對照抗體: Research Grade Vulinacimab (DHE16605) |
Catalog No.
DHE16605
Host species
Homo sapiens
Species reactivity
Human
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Concentration
1 mg/ml
Purity
>95% by SDS-PAGE.
Clonality
Monoclonal
Isotype
IgG1-kappa
Applications
Research Grade Biosimilar
Target
FLK-1, Kinase insert domain receptor, VEGFR2, Fetal liver kinase 1, CD309, Vascular endothelial growth factor receptor 2, Protein-tyrosine kinase receptor flk-1, FLK1, VEGFR-2, KDR
Purification
Protein A or G purified from cell culture supernatant.
Endotoxin level
Please contact with the lab for this information.
Expression system
XtenCHO
Accession
P35968
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
Alternative Names
HLX-06, HLX06, CAS: 2250342-36-8
Note
For research use only. Not suitable for clinical or therapeutic use.
成立日期 | 2021-04-08 (4年) | 注冊資本 | 700萬 |
員工人數(shù) | 100-500人 | 年營業(yè)額 | ¥ 1000萬-5000萬 |
主營行業(yè) | 生物化工,技術(shù)服務(wù) | 經(jīng)營模式 | 試劑 |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
詢價 |
VIP3年
|
維百奧(北京)生物科技有限公司
|
2024-12-30 | |
詢價 |
碧云天生物技術(shù)有限公司
|
2025-01-14 | ||
¥50 |
VIP6年
|
上??道噬锟萍加邢薰?/div>
|
2025-01-16 |